- Published at
- by marijuanastocks.com
mixed
mixed
Tetra Bio-Pharma Inc. (TBPMF) Announces a Delay in Filing 2022 Annual Financial Statements
Tetra Bio-Pharma Inc. Announces a Delay in Filing 2022 Annual Financial Statements…
News for Tetra Bio-Pharma Inc. (TBP.TO)
- Published at
- by marketscreener.com
positivepositiveTetra Bio-Pharma Announces Listing to OTCPink Market
MONTREAL, Feb. 10, 2023 /PRNewswire/ - Tetra Bio-Pharma Inc. , a leader in cannabinoid-derived drug discovery and development, today announced that its common shares began trading on the OTC... | February 10, 2023- Published at
- by prnewswire.com
positivepositiveREDUVO™ Marketing Approval on the Right Path
/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived drug discovery and...- Published at
- by benzinga.com
mixedmixedAI Study: Synthetic Cannabinoid + Favipiravir Presents Viable Treatment Against Viral Infections, Including COVID - Tetra Bio Pharma (OTC:TBPMF)
Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1), announced results from the study of Onternabez combined with Favipiravir against ARDS (acute respiratory distress syndrome), sepsis, and COVID-19 through PREPAiRE, an AI- Published at
- by marketscreener.com
positivepositiveTetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission
MONTREAL, Nov. 18, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development is providing its shareholders with a regulatory status update on... | November 18, 2022- Published at
- by prnewswire.com
positivepositiveTetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission
/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and...- Published at
- by benzinga.com
positivepositiveTetra Bio-Pharma Announces Second Closing Of Financing With Alpha Blue Ocean - Tetra Bio Pharma (OTC:TBPMF)
Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1), has closed the second tranche of its financing arrangement with Global Corporate Finance Opportunities 16, an investment vehicle advised by Alpha Blue Ocean, pursuant to the terms of an amended and- Published at
- by marketscreener.com
positivepositiveTetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean
OTTAWA, ON, Oct. 27, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. , a leader in cannabinoid-based drug discovery and development, announced today that the Company has closed the second tranche of... | October 27, 2022- Published at
- by marketscreener.com
neutralneutralTetra Bio Pharma : Financial Document
MANAGEMENT'S DISCUSSION TETRA BIO-PH RMAANDI C. ANALYSIS For the three and nine months ended August 31, 2022 ... | October 18, 2022- Published at
- by marijuanastocks.com
positivepositiveTetra Bio-Pharma Inc. (TBPMF) and Prepaire Jointly Apply to BARDA for Funding
Tetra and Prepaire Jointly Apply to BARDA for Funding Tetra Bio-Pharma Inc.…- Published at
- by globenewswire.com
mixedmixed- Published at
- by yahoo.com
positivepositiveTetra Bio-Pharma Inc. Announces $10 Million Bought Deal Offering of Units
NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/OTTAWA, ON, Feb. 22, 2021 /CNW/ - Tetra Bio-Pharma Inc.- Published at
- by markets.businessinsider.com
positivepositiveIIROC Trading Halt - TBP
TORONTO, Feb. 22, 2021 /CNW/ - The following issues have been halted by IIROC: Company: Tetra Bio-Pharma Inc.TSX Symbol: TBPAll Issues: YesReason:...- Published at
- by markets.businessinsider.com
positivepositiveIIROC Trading Halt - TBP
TORONTO, Feb. 22, 2021 /CNW/ - The following issues have been halted by IIROC: Company: Tetra Bio-Pharma Inc.TSX Symbol: TBPAll Issues: YesReason:...- Published at
- by marketscreener.com
neutralneutralToronto Stocks End Higher as Healthcare Gains -- Market Talk
17:27 ET - The benchmark S&P/TSX Composite Index rises 41.42 points or 0.2% to 17915.91 and the blue-chip S&P/TSX 60 Index rises 0.1% to 1060.75. Tetra Bio-Pharma's shares rise 24% after... | February 3, 2021